Typically transmitted vertically, parenterally, or sexually
Clinical Issues
•
10% of infected patients become chronically infected
400 million people worldwide have chronic HBV
•
Symptoms include mild flu-like syndrome, nausea, vomiting, jaundice
> 50% are asymptomatic
•
Lifelong risk of developing cirrhosis &/or HCC
•
Useful laboratory tests include serology for HBV viral antigens, anti-HBV antibodies, and HBV DNA viral load
Microscopic
•
Acute hepatitis B
Hepatocytic swelling, predominantly lobular inflammation, spotty necrosis
Severe cases may show confluent and bridging necrosis, collapse of hepatocytic cords, hepatocytic regeneration
•
Chronic hepatitis B
Portal-based inflammation with variably present ground-glass hepatocytes, “sanded nuclei” in hepatocytes, variable fibrosis
–
Stage of fibrosis indicates disease progression and is important therapeutic and prognostic indicator
•
Immunohistochemistry for HBcAG and HBsAG may be useful, but not invariably positive
TERMINOLOGY
Abbreviations
•
Hepatitis B virus (HBV)
Synonyms
•
Australia antigen: Hepatitis B surface antigen (HBsAg)
Definitions
•
Infection by HBV
Member of Hepadnaviridae family
Genome comprises partially double-stranded DNA virus
ETIOLOGY/PATHOGENESIS
Infectious Agents
•
Transmitted parenterally
Vertical transmission: Mothers to newborn infants
Horizontal transmission: Between young children
Sexual contact
•
Liver injury appears to be immune mediated
HBV-specific T cells play key role in pathogenesis and viral clearance
CLINICAL ISSUES
Epidemiology
•
Incidence
400 million people worldwide are chronically infected with HBV
Presentation
•
Acute hepatitis B
Symptoms include mild flu-like symptoms, nausea, vomiting, jaundice
< 1% develop fulminant liver failure leading to death or liver transplantation
Serum HBsAg and anti-HBc virus IgM Ab positive
•
Chronic hepatitis B
Serum HBsAg positive and anti-HBc virus IgM Ab negative
Laboratory Tests
•
Serology for HBV viral antigens: HBsAg, HBcAg, HBeAg
•
Serology for anti-HBV antibodies: Anti-HBs, anti-HBc, anti-HBe
•
Serum HBV DNA and viral load
Natural History
•
10% of infected individuals become chronically infected
•
Life-long risk of developing cirrhosis &/or HCC in chronic hepatitis B
Cirrhosis is not prerequisite for developing HCC
–
HBV viral genome can act as oncoprotein and intergrade into host genome
Related
Diagnostic Pathology Hepatobiliary and Pancreas